Day: October 6, 2023

In brief: Phaxiam, Abivax, Novartis

2023-10-06 14:00:00 Antibiotic resistance: Phaxiam wants to expand its phage portfolio Phaxiam Therapeutics, born from the merger between Erytech and Pherecydes, has signed a strategic

Read More »